At 8:54 p.m. CEST on October 2 2026, Kenvue stock traded at EUR 15.32 at Lang & Schwarz. The price was down 1.03 percent from the prior close of EUR 15.48.
That was the quote.
Kenvue says the global burden of oral disease has reached 3.73 billion cases, a figure it cites as part of the rationale for Oral Care Counts.
After-hours trading sets the immediate market frame
The price came from trading at Lang & Schwarz after the Xetra close. The quote was scheduled to update continuously through 11:00 p.m. CEST.
That gave investors a live view of further after-hours movement. It was not a final assessment of the next trading session.
The reported decline covers one price at one stated time. It does not establish why the stock moved.
LISTERINE targets prevention and access
LISTERINE launched Oral Care Counts on October 1 2026. The multiyear education and advocacy initiative focuses on oral health and daily prevention.
Kenvue tied the October 1 launch to World Smile Day and said the programme is intended to elevate oral health as an essential part of overall health.
The initiative is being activated in the United States and other key markets. Its stated focus is prevention, affordability and access.
That puts daily oral-health education beside the practical problem of obtaining care. Kenvue describes the routine as brushing, flossing and rinsing. It positions LISTERINE as a clinically proven essential-oil mouthrinse within comprehensive oral care.
Dividend date is set
The quarterly cash dividend is USD 0.21 per common share. It is payable on October 2 2026.
The payment applies to shareholders of record as of the close of business on September 21 2026, according to the Business Wire release. The dividend announcement was separate from the LISTERINE campaign.
The stock quote and the oral-care announcement belong to different reporting tracks. One records a market price. The other describes a company initiative.
The available information does not establish that the campaign caused the after-hours decline. It does show a consumer-health company pairing a shareholder payment with a prevention and access message in oral care.
For readers and dental professionals, the practical significance is limited but clear. Oral Care Counts is a corporate education and advocacy programme, not evidence of a new clinical standard.
The 3.07 percent finding and the broader case count give the initiative a stated public-health rationale. The stock price remains a time-specific market observation.
This article is not investment advice or a recommendation to buy or sell. Market transactions can result in significant losses.
